Clinical Trials Landscape Market will reach at a CAGR of 4.5% from 2019 to 2029 - PowerPoint PPT Presentation

About This Presentation

Clinical Trials Landscape Market will reach at a CAGR of 4.5% from 2019 to 2029


The study estimates industry-sponsored clinical trials to account for ~60% of overall spending in 2019, and in the foreseeable future. – PowerPoint PPT presentation

Number of Views:8
Slides: 10
Provided by: Umesh213
Category: Other


Transcript and Presenter's Notes

Title: Clinical Trials Landscape Market will reach at a CAGR of 4.5% from 2019 to 2029

Clinical Trials Landscape Market
  • March 2020

Report Id REP-GB-384 Published On Jul 11,2019
Category Healthcare, Pharmaceuticals Medical
AboutFuture Market Insights
Future Market Insights (FMI) is a premier
provider of syndicated research reports, custom
research reports, and consulting services. We
deliver a complete packaged solution, which
combines current market intelligence, statistical
anecdotes, technology inputs, valuable growth
insights, aerial view of the competitive
framework, and future market trends. We provide
research services at a global as well as regional
level key regions include GCC, ASEAN,
and BRIC. Our offerings cover a broad spectrum of
industries including Chemicals, Materials,
Energy, Technology, Healthcare, and Retail. We
have a global presence with delivery centers
across India specializing in providing global
research reports and country research reports.
FMI is headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Research Capabilities
Sector Coverage
  • Customized Research
  • Syndicated Research
  • Investment Research
  • Social Media Research

  • Automotive and Transportation
  • Electronics, Semiconductor, and ICT
  • Retail and Consumer Products
  • Industrial Automation and Equipment
  • Chemicals Materials
  • Food and Beverages
  • Services and Utilities
  • Energy, Mining, Oil, and Gas

Subscription Information

For detailed subscription information please
contact Hari. T (Sr. Manager - Global Business
Development) T 44 (0) 20 7692 8790 D 44
20 3287 4268 Email
Research Methodology (1/2)
  • Systematic Research Approach

In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc.
FMI formulates a detailed discussion guide to conduct expert and industry interviews
FMI develops a list of industry players (manufacturers), distributors, retailers and industry experts
FMI conducts interviews with industry experts, industry players, distributors and retailers
Data is validated by triangulation method, wherein secondary, primary and FMI analysis contribute to the final data
Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry
FMI delivers industry insights and information in the required format (PDF)
  • Identifying key opinion leaders
  • Questionnaire design
  • In-depth interviews
  • Coverage across value chain
  • Key industry experts
  • Channel study
  • Developments
  • Market dynamics
  • Products
  • Conclusions

  • Market participants
  • Key strengths
  • Product portfolio
  • Mapping as per value chain
  • Key focus segments

Primary Research
Secondary Research
Paid Publications
  • Linkedin
  • Zoominfo
  • Salesforce
  • Avention
  • Factiva
  • GBI
  • Genios
  • Meltwater
  • Company websites
  • Company annual reports
  • White papers
  • Financial reports

includes sources of databases
Clinical Trials Landscape Market Analysis
A new study of Future Market Insights (FMI)
estimates the global spending on clinical
trials in 2019 at US 90 Bn, recording a 4
Y-o-Y over 2018. The healthcare sector is closing
in on a new era of clinical trials, which are
more engaged with patients, streamlined and
connected. With development costs reaching record
highs and patents approaching cliffs, companies
are strengthening their RD efforts to keep pace
with change. Medical device and pharma giants are
already eyeing better approaches for clinical
trials, implementing a combination of their
current systems and better technologies to ebb
challenges in critical areas orphan drugs and
rare diseases. The ubiquity digital technologies
is evidently growing, as these (including but not
limited to ingestible devices, sensors, and
wearable health monitors) hold the potential to
disrupt the aspects of clinical trials. Digital
technologies are revolutionizing the antiquated
process of new drug development, even as
optimizing the way health data is collected,
measured, and assessed. According to the study,
the clinical trials landscape is witnessing a
paradigm shift toward patient centricity, in a
bid to incorporate perspective of patients during
the clinical trial design. Clinical trial
sponsors have aligned their methods with the
voice of patients, by launching communication
channels during the study's execution. Key
enterprises are adopting unconventional
approaches by implementing site-centric method,
using operational support systems and technology
for bringing studies to the trial-naïve
Clinical Trials Landscape Market Analysis
Industry Sponsors Account for Majority Clinical
Trial Spending The most remarkable advances in
medicine are realized from sponsorships of
companies for clinical trials, in the
anticipation of turning a profit. A notable
percentage of clinical trials being conducted to
support approval of vaccines, devices, or drugs,
and track their safety, have been
industry-sponsored in recent years. The study
estimates industry-sponsored clinical trials to
account for 60 of overall spending in 2019, and
in the foreseeable future. Recent studies state
that industry-sponsored trials yield positive
results compared to academic-run trials, which
also account for a significant share of clinical
trial spending. According to FMI, sponsors, such
as academic institutes, research institutes and
medical centers, are estimated to account for
30 clinical trial spending in 2019. As the
imperativeness of evidence-based therapies
continue to be progressively emphasized, most of
the randomized clinical trials are driven by the
ability of developing profitable new therapies.
Guidelines recommended by regulatory bodies for
clinical trial enrichment, and risk-based
monitoring are likely to lay the groundwork for
more targeted approach toward cost-intensive
clinical trials.
Clinical Trials Landscape Market Analysis
The study opines that North America and Europe
will continue to lead the clinical trials
landscape, collectively accounting for 80 of
global spending. These regions present a
standardized and favorable environment for the
clinical trials landscape, in light of their
economic vigor that enables them to benefit from
most of the technology disruptions prior to other
nations. Pharmaceutical and medical device giants
in these two regions are adopting AI for
disrupting every stage of the clinical trial,
which range from linking studies to eligible
patients, to data collection and
adherence. According to the study, opportunities
abound for conducting clinical trials in
developing economies, such as in East Asia and
South Asia, owing to the access to huge patient
pool. Sponsors are likely to realize greater
success in these regions as low government
healthcare budgets represent cost-effective
methods of providing patients with access to
innovative therapies. Additionally, conducting
clinical trials in these regions comes with other
broader advantages, including pragmatic
efficient regulatory pathway, and tax incentives
for conducting the trials.
Clinical Trials Landscape Market Analysis
  • The study offers a long-term forecast of the
    clinical trials landscape for the period between
    2019 and 2029. The clinical trials landscape is
    projected to record a 4.5 CAGR through 2029.
  • Request for covid19 Impact Analysis
  • Press Release Source https//
  • More from Healthcare, Pharmaceuticals and Medical
    devices Market Insights
  • Hearing Implants Market
  • Specialty Active Pharmaceutical Ingredients (API)
  • Europe Platelet Rich Plasma (PRP) Market

Clinical Trials Landscape Market Analysis
About Future Market Insights (FMI) Future Market
Insights (FMI) is a leading provider of market
intelligence and consulting services, serving
clients in over 150 countries. FMI is
headquartered in London, the global financial
capital, and has delivery centers in the U.S. and
India. FMIs largest market research reports and
industry analysis help businesses navigate
challenges and take critical decisions with
confidence and clarity amidst breakneck
competition. Contact Mr. Abhishek
Budholiya Unit No AU-01-H Gold Tower (AU), Plot
No JLT-PH1-I3A, Jumeirah Lakes Towers,
Dubai, United Arab Emirates MARKET ACCESS DMCC
Initiative For Sales Enquiries sales_at_futuremarket For Media Enquiries press_at_futuremark Future Market Insights
To know more about us, please visit our website For sales queries
or new topics email us on sales_at_futuremarketinsi For media queries, contact the press
office at For
other queries contactHari. T (Sr. Manager -
Global Business Development) Future Market
Insights 3rd Floor,207 Regent Street, London
W1B 3HH T 44 20 7692 8790 D 44 20 3287
4268 Email
Thank You
Future Market Insights Global Consulting
Private Limited (FMI)
Write a Comment
User Comments (0)